Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2019-02-27 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2018年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2018 年年度报告摘要" which translates to "2018 Annual Report Summary". It contains detailed financial data for the year 2018, including revenue, net profit, quarterly financial data, changes in accounting policies, business overview, shareholder information, and management discussion. The length of the document (11,392 characters) and the depth of financial and operational information indicate it is a substantive financial report rather than a brief announcement or summary. The document is clearly a form of annual report, providing comprehensive financial performance and business analysis for the fiscal year 2018. Therefore, it fits the definition of an Annual Report (10-K). FY 2018
2019-02-27 Chinese
公司章程（2019年2月）
Governance Information Classification · 100% confidence The document is titled as the "Articles of Association" (公司章程) of 嘉事堂药业股份有限公司, which is a legal and governance document outlining the company's organizational structure, shareholder rights, board responsibilities, and other internal rules. It references the Company Law and Securities Law, and details chapters on shareholders, board of directors, management, financial accounting, and amendments to the articles. This is a governance-related document, not a financial report, earnings release, or announcement. It is a detailed internal governance document rather than a proxy statement or remuneration report. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full articles, not a brief announcement or summary.
2019-02-27 Chinese
关于修订公司章程的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of 嘉事堂药业股份有限公司 regarding proposed amendments to the company's articles of association (公司章程). It details changes to the company's governance structure, including the establishment of a party committee and adjustments to board and supervisory roles. The document states that these amendments will be submitted to the 2018 annual shareholders' meeting for approval and subsequent registration with regulatory authorities. The text is relatively short (1765 characters) and serves as a formal notice of proposed governance changes rather than the full governance report or the actual amended articles. It does not contain financial data, audit information, or detailed management discussion. Therefore, it fits best as a Regulatory Filing (RNS) because it is a formal regulatory announcement about governance changes but not a full governance report or management information filing.
2019-02-27 Chinese
2018年企业社会责任报告
Environmental & Social Information Classification · 95% confidence The document is titled "2018 年企业社会责任报告" (2018 Corporate Social Responsibility Report) and contains detailed information about the company's social responsibility activities, governance, internal control, employee rights, quality management, customer rights, and social welfare initiatives. It references compliance with Shenzhen Stock Exchange guidelines on social responsibility and covers the full year 2018. The content focuses on environmental, social, and governance (ESG) factors, including community engagement, employee welfare, and corporate governance practices. There is no indication that this is an annual financial report, earnings release, or other financial filing. The document is comprehensive and substantive, not a brief announcement or certification. Therefore, it fits the category of Environmental & Social Information (SR).
2019-02-27 Chinese
华泰联合证券有限责任公司关于公司2018年度募集资金使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from Huatai United Securities Co., Ltd., acting as the sponsor institution, regarding the special verification opinion on the use of raised funds by Jiashitang Pharmaceutical Co., Ltd. for the year 2018. It includes specifics about the amount of funds raised, their allocation, storage, actual usage, project progress, and compliance with regulations. The document references regulatory approvals, detailed financial figures related to fundraising, and the sponsor's verification opinion. It is not a general annual report or earnings release but a specialized audit or verification report focused on the use of fundraising proceeds. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report on the use of raised funds, not a full annual report or other category. The document length (7166 characters) and content confirm it is a full report, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2018
2019-02-27 Chinese
内部控制规则落实自查表
Regulatory Filings Classification · 95% confidence The document is titled as an "内部控制规则落实自查表" which translates to "Internal Control Rules Implementation Self-Inspection Form." It contains detailed internal control checklists related to internal audit operations, information disclosure, insider trading controls, fundraising, related party transactions, external guarantees, major investments, and other important matters. The document is a self-assessment or internal control checklist rather than a formal audit report or annual report. It does not contain financial statements or substantive financial data. It is also not a brief announcement or a certification letter. The document is a regulatory compliance or internal control self-assessment report, which does not fit into categories like Annual Report (10-K), Audit Report (AR), or Interim Report (IR). Given the nature of the document, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories.
2019-02-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.